270 results on '"Elneil, Sohier"'
Search Results
2. What are the health needs of women with female genital mutilation going through menopause?
3. The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
4. Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
5. The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel
6. Pharmacological Treatment of Chronic Pelvic Pain
7. Pharmacological Treatment of Chronic Pelvic Pain
8. Postoperative outcomes and urodynamic findings after continence mesh removal
9. Sensory mechanisms in the rat and human urinary bladder
10. Demand and capacity to integrate pelvic organ prolapse and genital fistula services in low-resource settings
11. Mesh-Associated Pain Syndrome: Predictors for Continence and Prolapse Mesh Removal Surgery in a Single Centre
12. Postoperative outcomes and urodynamic findings after continence mesh removal.
13. The ELEMI healthcare professional Study
14. Gynaecological pathology in women with Fowler's syndrome
15. Global efforts for effective training in fistula surgery
16. Sacral Neuromodulation Outcomes in Male Patients with Chronic Urinary Retention
17. Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance)
18. A systematic review and meta-analysis of digital application use in clinical research in pain medicine
19. Optimizing the Duration of Assessment of Stage-1 Sacral Neuromodulation in Nonobstructive Chronic Urinary Retention
20. Erratum to: Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance)
21. The Possible Role of Opiates in Women with Chronic Urinary Retention: Observations from a Prospective Clinical Study
22. Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
23. Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis
24. Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks
25. In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results
26. EAU Guidelines on Chronic Pelvic Pain
27. Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration
28. Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
29. Cadherin-11 Up-Regulation in Overactive Bladder Suburothelial Myofibroblasts
30. Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
31. Complex pelvic floor failure and associated problems
32. Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
33. What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection
34. Pregnancy in women with Fowler’s syndrome treated with sacral neuromodulation
35. Management of chronic primary pelvic pain syndromes
36. Recurrent Urinary Tract Infections Associated with Gynecological Disorders
37. Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity
38. Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity
39. Urinary retention in women and sacral neuromodulation
40. sj-pdf-1-whe-10.1177_17455065211019717 – Supplemental material for A systematic review and meta-analysis of the Endometriosis and Mental-Health Sequelae; The ELEMI Project
41. sj-pdf-2-whe-10.1177_17455065211019717 – Supplemental material for A systematic review and meta-analysis of the Endometriosis and Mental-Health Sequelae; The ELEMI Project
42. sj-pdf-3-whe-10.1177_17455065211019717 – Supplemental material for A systematic review and meta-analysis of the Endometriosis and Mental-Health Sequelae; The ELEMI Project
43. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntingtonʼs disease
44. Urinary retention
45. Evaluation and management of neurogenic sexual dysfunction
46. Neurogenic bladder dysfunction: surgical interventional approaches
47. Management of chronic primary pelvic pain syndromes.
48. The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel
49. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab
50. A systematic review and meta-analysis of the Endometriosis and Mental-Health Sequelae; The ELEMI Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.